Post-earnings recap
Reported
Tue, May 5, 2026
EPS actual
$0.05
EPS est.
$-0.05
EPS surprise
+194.34%
1-day move
+2.65%
The Chemours Company's earnings report showed a significant positive surprise in EPS, which likely contributed to the stock's 2.65% increase. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may view the EPS beat as a sign of better-than-expected profitability, but the lack of revenue data could lead to cautious sentiment moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.05 | $-0.04 | +194.34% |
| Revenue | N/A | $1.4B | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
The Chemours Company (CC) is a global leader in the diversified chemicals sector, known for its innovative products in titanium technologies, fluoroproducts, and chemical solutions. As a key player in materials, Chemours' performance is closely tied to industrial demand and environmental regulations, making it an important company to watch in the current economic landscape.
Last quarter
In Q4 2025, Chemours reported an EPS of $0.05, significantly beating expectations of $0.00. However, the stock fell 3.50% the following day, indicating mixed market reactions despite the positive earnings surprise.
Management promises and guidance
EPS beat streak
0Q
EPS beat rate
75%
Avg EPS surprise
+334.83%
Avg 1-day reaction
+3.02%
Analysts are cautiously optimistic about Chemours' upcoming earnings, with expectations of a slight loss in EPS but stable revenue figures. The market is closely watching for any signs of recovery in demand and cost management strategies.
Bull case
If Chemours can exceed EPS expectations and show strong revenue growth, it could signal a robust recovery in demand and operational efficiency, leading to positive market sentiment.
Bear case
Conversely, if the company reports a larger loss than expected or provides weak guidance, it could raise concerns about ongoing challenges in the market and lead to a negative reaction from investors.
Key metrics to watch
Earnings Per Share (EPS)
$-0.04EPS is a crucial indicator of profitability and helps investors gauge the company's financial health.
Revenue
$1.4BRevenue figures provide insight into the company's sales performance and overall market demand.
The print will turn on these.
Q1
Will Chemours achieve a positive EPS this quarter, or will it fall deeper into the negative range?
A positive EPS would indicate strong operational performance, while a deeper loss could signal ongoing challenges in the market.
Q2
What are the revenue figures for the quarter, and how do they compare to the consensus estimate of $1.4B?
Revenue performance is critical for assessing demand and the company's market position, impacting investor confidence.
—
Est. EPS
$0.01
Est. Rev
$918M
Impl. Move
±9.1%
Why consensus could be wrong
The Street may be underestimating Chemours' ability to manage costs effectively, which could lead to a better-than-expected EPS despite current challenges.
Supporting evidence
The company has a history of beating EPS estimates, with a 75% success rate over the last eight quarters.
Recent operational improvements and cost management strategies may not be fully reflected in analyst expectations.
Key risk
If Chemours reports an EPS above $0.00, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance hinges on the company's ability to manage costs and meet market demand amidst economic uncertainties.
Bull confirmed if
An EPS of $0.03 or better would confirm the bull case, indicating strong operational performance.
Bear confirmed if
An EPS of $-0.14 or worse would confirm the bear case, raising concerns about demand and profitability.
What the market is pricing for the move.
Implied Move
±11.20%
Historical Avg
±4.5%
The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.
Options are pricing ±10.8% while CC has averaged ±4.5% over the last 8 prints — setup is pricing rich.
ATM IV
1.3%
30d HV
50.3%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Materials
Fade rate: 5 of 11 (45%)
This setup has occurred 30 times across Materials in the last 2 years. 5 of 11 faded and 6 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 3.2%, with a raw directional average of -0.1% (modestly negative historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
91.38%
of float
Insider
0.37%
of float
Holders
615
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
23,283,074 sh · $325.5M
15.47%
4.0%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Chemours beats expectations, history suggests a potential stock increase of around +2.22%, confirming a positive outlook.
In line / cautious
An in-line result may lead to a muted response, as investors await further commentary on future guidance and market conditions.
Miss
If the company misses expectations, history suggests a potential decline of around -1.78%, reflecting investor disappointment.
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
10,568,867 sh · $147.8M
7.02%
2.4%
Vanguard Capital Management LLC
6,784,588 sh · $94.8M
4.51%
0.2%
State Street Corporation
6,115,375 sh · $85.5M
4.06%
-0.1%
Ameriprise Financial, Inc.
4,924,004 sh · $68.8M
3.27%
1.8%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.